Connexion
Identifiant
Mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 

Accueil Zonebourse  >  Actions  >  Euronext Paris  >  NicOx SA    NCOX   FR0000074130

NICOX SA (NCOX)

Mes dernières consult.
Top consultations
1796
SynthèseGraphiquesActualitésAnalysesAgendaSociétéFinancesConsensusRévisionsFondsCommunauté 
Métier
Logo NicOx SA
Developes and manufactures biopharmaceuticals

Nicox SA is an international commercial-stage company focused on the ophthalmic market.

It seeks and evaluate commercial and late-stage ophthalmic products.

The company was founded by Piero Del Soldato, Michele Garufi and Elizabeth Marie Robinson on February 15, 1996 and is headquartered in Sophia-Antipolis, France.
Dirigeants
Nom AgeDepuisTitre
Michele Garufi611996Chairman & Chief Executive Officer
Philippe Masquida542012Executive Vice President & MD-European Operations
Sandrine Gestin481999Finance Director
Michael Bergamini, PhD-2014Chief Scientific Officer & Executive VP
Jean-François Labbé, MBA662010Director
Birgit Stattin Norinder682011Director
Adrienne L. Graves, PhD612014Director
Luzi Andreas von Bidder632014Director
Lester J. Kaplan, PhD652014Director
Gavin M. Spencer, PhD452005Executive Vice President-Corporate Development
Actions
Vote NombreFlottantAutocontrôleFlottant Total
Action A 1 19 848 330 14 035 919 70.7% 0 0.0% 70.7%
Actionnaires
Nom Actions%
Bay City Capital LLC 938 506 4,10%
Akorn, Inc. 881 046 3,85%
Ora, Inc. 850 212 3,72%
Bpifrance Participations SA /PRIVATE EQUITY/ 790 515 3,46%
New Enterprise Associates LLC 727 821 3,18%
Health Care Ventures, Inc. 727 821 3,18%
Credit Suisse AG 494 120 2,16%
Petrone Group SRL 434 669 1,90%
Financière Lb SAS 240 558 1,05%
Michele Garufi 181 052 0,79%
Secteur
Santé
Recherche pharmaceutique et médicale
 Produits pharmaceutiques
  Produits pharmaceutiques
   Pharmacies spécialisées et de pointe
Publicité
Secteur Produits pharmaceutiques
CroissanceRentabilité
ABBVIE INC
BIOGEN INC
MERCK KGAA
KYOWA HAKKO KIRIN..
JAZZ PHARMACEUTIC..
MALLINCKRODT PLC
ZHANGZHOU PIENTZE..
YUHAN CORPORATION
COSMO PHARMACEUTI..
THERAPEUTICSMD IN..
INDIVIOR PLC
NICHI-IKO PHARMAC..
ADVANCED ACCELERA..
KISSEI PHARMACEUT..
-
DONG-A ST CO LTD
LG LIFE SCIENCES,..
REPLIGEN CORPORAT..
MAYNE PHARMA GROU..
HUONS CO LTD
SUPERNUS PHARMACE..
Secteur Produits pharmaceutiques
NicOx SA : Connexions
Partners For Utvecklingsinvesteringar Inom Life Sciences AB
Keck Graduate Institute of Applied Life Sciences
Wingfirm Pharma AB
Ferring Holding SA
Pan-American Ophthalmological Foundation
Navigation Dynamics AB
Envisia Therapeutics, Inc.
The Clinical Research Institute of the Foundation
American Academy of Ophthalmology, Inc.
Relivia SRL
Delife SRL
Himalayan Cataract Project
Women in Ophthalmology
The Association for Research in Vision & Ophthalmology
American Glaucoma Society
American Academy of Ophthalmology Foundation
The American Society of Cataract & Refractive Surgery
Sequana Medical AG
Glaucoma Research Foundation
Ferring International Center SA
Aerpio Therapeutics, Inc.
Neurotech Pharmaceuticals, Inc. (United States)
Encore Vision, Inc.
Medinox, Inc.
KeepYourSight Foundation
FFB Clinical Research Institute
Coordonnées société
Nicox SA
Drakkar 2 - Bât D
2405 route des Dolines
Sophia-Antipolis, Provence-Alpes-Cote-dAzur 06560

Phone : +33.4.97.24.53.00
Fax : +33.4.97.24.53.99
Web : www.nicox.com
© 2016 People , Fundamentals and Ownership